[1] LIU H,GU H,KUTBI EH,et al.Association of IGF-1 and IGFBP-3 levels with gastric cancer:A systematic review and meta-analysis[J].Int J Clin Pract,2021,75(11):e14764. [2] 郭益辰,李卫平,杨瑞婷,等.ZEB1、AR、E-Cadherin和N-Cadherin在前列腺癌组织中的表达及意义[J].现代泌尿外科杂志,2023,28(7):627-631. [3] 张悦健,何甜甜,林陶秀,等.琥珀散对人MenSCs植入式子宫内膜异位症裸鼠异位病灶及Beclin1、ZEB1表达的影响[J].药物评价研究,2023,46(2):294-304. [4] 聂伟,马迎萍.SLUG、ZEB1在宫颈癌组织中的表达及与预后的关系[J].现代肿瘤医学,2022,30(8):1454-1458. [5] 朱旭超,窦长松,张钰,等.黑质LAMP2A过表达改善帕金森病恒河猴模型的运动功能[J].中国比较医学杂志,2022,32(4):7-13. [6] 中国医师协会结直肠肿瘤专业委员会外科专委会.中国结直肠癌县域医师诊疗指南-外科部分(2019版草案)[J].中华结直肠疾病电子杂志,2019,8(5):433-438. [7] LARSSON S C,BURGESS S.Causal role of high body mass index in multiple chronic diseases:A systematic review and meta-analysis of Mendelian randomization studies[J].BMC Med,2021,19(1):320. [8] CUK P,KJÆR M D,MOGENSEN C B,et al.Short-term outcomes in robot-assisted compared to laparoscopic colon cancer resections:A systematic review and meta-analysis[J].Surg Endosc,2022,36(1):32-46. [9] IRRAZABAL T,THAKUR B K,CROITORU K,et al.Preventing colitis-associated colon cancer with antioxidants:A systematic review[J].Cell Mol Gastroenterol Hepatol,2021,11(4):1177-1197. [10] REZAEI S,DE OLIVEIRA L C,GHANAVATI M,et al.The effect of anamorelin(ONO-7643)on cachexia in cancer patients:Systematic review and meta-analysis of randomized controlled trials[J].J Oncol Pharm Pract,2023,29(7):1725-1735. [11] 钟淙,石琴,章超.lncRNA MALAT1调控miR-144-3p/ZEB1对肺癌放射敏感性的影响[J].实用肿瘤杂志,2022,37(4):307-314. [12] 黄金梅,唐婷,韦柳叶,等.MEBT/MEBO对糖尿病大鼠难愈合创面中ZEB1/LAMA3/ITGA3信号通路表达的影响[J].现代中西医结合杂志,2023,32(10):1322-1329. [13] 陈昊,方攀奇,刘桐言,等.肿瘤相关性成纤维细胞高表达LncRNA ZEB1-AS1促进肺腺癌血管生成的功能机制[J].医学研究生学报,2022,35(7):680-686. [14] 张旭东,单李天一,王蓉,等.沉默调节蛋白3通过mTOR信号途径调节溶酶体功能抑制U87细胞凋亡[J].陆军军医大学学报,2023,45(18):1916-1926. [15] TZENIOS N,TAZANIOS M E,CHAHINE M.The impact of body mass index on prostate cancer:An updated systematic review and meta-analysis[J].Medicine(Baltimore),2022,101(45):e30191. [16] LI X,LI J,HU Q,et al.Association of physical weight statuses defined by body mass index(BMI)with molecular subtypes of premenopausal breast cancer:A systematic review and meta-analysis[J].Breast Cancer Res Treat,2024,203(3):429-447. [17] LI H,BOAKYE D,CHEN X,et al.Association of body mass index with risk of early-onset colorectal cancer:Systematic review and Meta-Analysis[J].Am J Gastroenterol,2021,116(11):2173-2183. [18] 赵维波,孔令甲,敬长春.白花丹素调控锌指E盒结合ZEB1的表达对结直肠癌细胞增殖、凋亡的影响[J].河北医药,2022,44(22):3380-3383. [19] 杨书瀚,裴筱涵,祁义军.LAMP5在结直肠癌发生发展和预后中的作用[J].安徽医科大学学报,2022,57(8):1338-1344. [20] 张芳芳,张可刚,赵新凤,等.缺氧缺血性脑损伤新生大鼠大脑皮层中LAMP-2A和HSC70的表达变化及意义[J].中国妇幼保健,2023,38(9):1696-1699. [21] 袁祎,丁森君,李丽洁,等.卵巢癌组织锌指E盒同源结合蛋白1、微小RNA-574-3p的表达及其临床意义研究[J].中国性科学,2022,31(7):63-67. [22] 金亚,张教国.LncRNA XIST调控miR-200b/ZEB1轴参与儿童急性髓系白血病阿柔比星耐药的机制研究[J].中国免疫学杂志,2022,38(20):2450-2454. [23] 张翔,周宏,周云海.胃癌中LAMP5表达及预后意义分析[J].交通医学,2023,37(1):33-38. [24] 阿孜古丽·阿布都热合曼,李宇翔,赵寰宇,等.三阴性乳腺癌中溶酶体相关膜蛋白-2表达水平的临床意义及预后价值[J].转化医学杂志,2022,11(6):351-354. [25] 张倩,段婷婷,任玉宝.结直肠癌组织中PLOD2、ZEB1表达变化及意义[J].山东医药,2022,62(10):67-70. |